Free Trial

Owens & Minor, Inc. (NYSE:OMI) Shares Sold by Phocas Financial Corp.

Owens & Minor logo with Medical background

Phocas Financial Corp. lowered its position in Owens & Minor, Inc. (NYSE:OMI - Free Report) by 40.0% in the 3rd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 216,964 shares of the company's stock after selling 144,471 shares during the period. Phocas Financial Corp. owned 0.28% of Owens & Minor worth $3,404,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Quarry LP boosted its stake in shares of Owens & Minor by 290.1% in the 2nd quarter. Quarry LP now owns 2,099 shares of the company's stock worth $28,000 after buying an additional 1,561 shares during the last quarter. Innealta Capital LLC purchased a new position in shares of Owens & Minor in the 2nd quarter worth $43,000. DekaBank Deutsche Girozentrale boosted its stake in shares of Owens & Minor by 76.6% in the 2nd quarter. DekaBank Deutsche Girozentrale now owns 3,126 shares of the company's stock worth $43,000 after buying an additional 1,356 shares during the last quarter. Blue Trust Inc. boosted its stake in shares of Owens & Minor by 176.8% in the 3rd quarter. Blue Trust Inc. now owns 2,787 shares of the company's stock worth $44,000 after buying an additional 1,780 shares during the last quarter. Finally, Allspring Global Investments Holdings LLC boosted its stake in shares of Owens & Minor by 100.6% in the 2nd quarter. Allspring Global Investments Holdings LLC now owns 6,071 shares of the company's stock worth $82,000 after buying an additional 3,044 shares during the last quarter. Institutional investors own 98.04% of the company's stock.

Wall Street Analyst Weigh In

Several equities analysts recently weighed in on the company. UBS Group lowered their target price on Owens & Minor from $28.00 to $25.00 and set a "buy" rating on the stock in a research report on Tuesday, November 5th. JPMorgan Chase & Co. decreased their price target on Owens & Minor from $22.00 to $18.00 and set an "underweight" rating on the stock in a report on Wednesday, August 21st. Barclays decreased their price target on Owens & Minor from $18.00 to $14.00 and set an "equal weight" rating on the stock in a report on Tuesday, November 5th. StockNews.com cut Owens & Minor from a "buy" rating to a "hold" rating in a report on Monday, August 26th. Finally, Robert W. Baird decreased their price target on Owens & Minor from $19.00 to $14.00 and set a "neutral" rating on the stock in a report on Tuesday, November 5th. Two investment analysts have rated the stock with a sell rating, five have assigned a hold rating and two have assigned a buy rating to the company. According to data from MarketBeat, the stock currently has an average rating of "Hold" and a consensus price target of $18.50.

Get Our Latest Analysis on OMI

Owens & Minor Price Performance

Shares of Owens & Minor stock traded up $0.16 during trading hours on Tuesday, reaching $12.42. The stock had a trading volume of 159,110 shares, compared to its average volume of 828,384. The stock's 50 day moving average is $13.96 and its 200 day moving average is $15.34. The firm has a market capitalization of $957.71 million, a PE ratio of -18.85, a PEG ratio of 0.42 and a beta of 0.41. Owens & Minor, Inc. has a twelve month low of $11.42 and a twelve month high of $28.35. The company has a current ratio of 1.09, a quick ratio of 0.45 and a debt-to-equity ratio of 2.11.

Owens & Minor (NYSE:OMI - Get Free Report) last released its quarterly earnings results on Monday, November 4th. The company reported $0.42 earnings per share for the quarter, topping the consensus estimate of $0.41 by $0.01. The firm had revenue of $2.72 billion during the quarter, compared to the consensus estimate of $2.68 billion. Owens & Minor had a negative net margin of 0.46% and a positive return on equity of 14.60%. The company's revenue for the quarter was up 5.0% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.44 EPS. Equities analysts expect that Owens & Minor, Inc. will post 1.49 earnings per share for the current fiscal year.

About Owens & Minor

(Free Report)

Owens & Minor, Inc, together with its subsidiaries, operates as a healthcare solutions company worldwide. It operates through Products & Healthcare Services and Patient Direct segments. The Products & Healthcare Services segment offers a portfolio of products and services to healthcare providers and manufacturers.

Featured Stories

Institutional Ownership by Quarter for Owens & Minor (NYSE:OMI)

Should you invest $1,000 in Owens & Minor right now?

Before you consider Owens & Minor, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Owens & Minor wasn't on the list.

While Owens & Minor currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

’Best Report in 2 Years’: NVIDIA Earnings Crushes Expectations Again
Palantir and the NASDAQ 100: What’s the Next Big Stock Swing for This AI Giant?
Rocket Lab Stock Explodes Higher—What’s Next for This Space Pioneer?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines